Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Stock
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
14.3M
-
Shares change
-
-3.75M
-
Total reported value, excl. options
-
$19.8M
-
Value change
-
-$6.71M
-
Put/Call ratio
-
0.5
-
Number of buys
-
21
-
Number of sells
-
-32
-
Price
-
$1.39
Significant Holders of VYNE THERAPEUTICS INC COM - Stock (VYNE) as of Q3 2021
70 filings reported holding VYNE - VYNE THERAPEUTICS INC COM - Stock as of Q3 2021.
VYNE THERAPEUTICS INC COM - Stock (VYNE) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.3M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.44M shares), PERCEPTIVE ADVISORS LLC (2.33M shares), FRANKLIN RESOURCES INC (1.92M shares), RENAISSANCE TECHNOLOGIES LLC (1.25M shares), DSC Advisors, L.P. (1.1M shares), BlackRock Inc. (1.04M shares), 683 Capital Management, LLC (715K shares), STATE STREET CORP (544K shares), GEODE CAPITAL MANAGEMENT, LLC (470K shares), and MILLENNIUM MANAGEMENT LLC (432K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.